2022
DOI: 10.1212/con.0000000000001151
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies

Abstract: PURPOSE OF REVIEW: This article summarizes the underlying biology and current diagnostic and treatment strategies for the cognitive and neuropsychiatric features of Parkinson disease (PD) and dementia with Lewy bodies (DLB).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 68 publications
0
6
0
Order By: Relevance
“…[8, 9, 14] However, to the best of our knowledge, this is the rst study to report the increased risk of PPH in DLB patients. Considering both DLB-related negative health outcomes, [9,13,21,29] and adverse events and complications related to OH and PPH, as signs of dysautonomia, it is clear that the prevention of such outcomes is indispensable to ensure better management of DLB. [8, 9,14] Although delayed OH was signi cantly higher in DLB patients than in control, this difference between the groups disappeared after the adjustment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[8, 9, 14] However, to the best of our knowledge, this is the rst study to report the increased risk of PPH in DLB patients. Considering both DLB-related negative health outcomes, [9,13,21,29] and adverse events and complications related to OH and PPH, as signs of dysautonomia, it is clear that the prevention of such outcomes is indispensable to ensure better management of DLB. [8, 9,14] Although delayed OH was signi cantly higher in DLB patients than in control, this difference between the groups disappeared after the adjustment.…”
Section: Discussionmentioning
confidence: 99%
“…Considering both DLB-related negative health outcomes, [9,13,21,29] and adverse events and complications related to OH and PPH, as signs of dysautonomia, it is clear that the prevention of such outcomes is indispensable to ensure better management of DLB. [8, 9,14] Although delayed OH was signi cantly higher in DLB patients than in control, this difference between the groups disappeared after the adjustment. Indeed, a higher frequency is an expected outcome, as delayed OH is likely to be an early and milder form of OH in such patients.…”
Section: Discussionmentioning
confidence: 99%
“…Further, the new MDS-PD criteria recommend that for patients with a diagnosis of DLB made according to consensus criteria, the diagnosis can optionally be qualified as PD (DLB subtype). For more information, refer to the article “Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies” by Daniel Weintraub, MD, and David Irwin, MD, 40 in this issue of Continuum .…”
Section: Diagnosis Of Parkinson Diseasementioning
confidence: 99%
“…A meta-analysis of cholinesterase inhibitors demonstrated improvement in cognitive functions in patients with PD and dementia 95 ; however, this has not been demonstrated for cognitive impairment without dementia in PD 36 . For more information, refer to the article “Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies” by Daniel Weintraub, MD, and David Irwin, MD, 40 in this issue of Continuum .…”
Section: Treatment Of Nonmotor Symptomsmentioning
confidence: 99%
“…Other neuropsychiatric disorders, including depression and anxiety, are also part of the syndrome of prodromal α-synucleinopathy 2,5,17 . For more information on cognitive and neuropsychiatric manifestations of PD and DLB, refer to the article “Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies” by Daniel Weintraub, MD, and David Irwin, MD, 27 in this issue of Continuum .…”
Section: Cognitive Dysfunction and Other Neuropsychiatric Disordersmentioning
confidence: 99%